Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN in Moderate to Severe Non-malignant Pain
NCT01167127Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Jun 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone + naloxone in pain, sponsored by Mundipharma. Started Jun 2009; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
pain
Beyond the preview
Go deeper on NCT01167127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167127.